These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15694536)

  • 1. [Antineutrophil cytoplasmic antibodies in cystic fibrosis. Frequency and significance].
    Berlie I; Leboucher B; Leblanc M; Troussier F; Pellier I; Chevailler A; Giniès JL
    Arch Pediatr; 2005 Feb; 12(2):140-3. PubMed ID: 15694536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization].
    Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L
    Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-neutrophil cytoplasmatic antibodies and lung disease in cystic fibrosis.
    Dorlöchter L; Carlsson M; Olafsdottir EJ; Røksund OD; Rosendahl K; Fluge G
    J Cyst Fibros; 2004 Aug; 3(3):179-83. PubMed ID: 15463905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis.
    Carlsson M; Eriksson L; Pressler T; Kornfält R; Mared L; Meyer P; Wiik A; Wieslander J; Segelmark M
    J Cyst Fibros; 2007 May; 6(3):228-33. PubMed ID: 17166780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods.
    Pressler T; Karpati F; Granström M; Knudsen PK; Lindblad A; Hjelte L; Olesen HV; Meyer P; Høiby N;
    J Cyst Fibros; 2009 Jan; 8(1):37-42. PubMed ID: 18835753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential cytokine profile in children with cystic fibrosis.
    Brazova J; Sediva A; Pospisilova D; Vavrova V; Pohunek P; Macek M; Bartunkova J; Lauschmann H
    Clin Immunol; 2005 May; 115(2):210-5. PubMed ID: 15885645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis.
    Lachenal F; Nkana K; Nove-Josserand R; Fabien N; Durieu I
    Eur Respir J; 2009 Nov; 34(5):1079-85. PubMed ID: 19443536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis.
    Milagres LG; Castro TL; Garcia D; Cruz AC; Higa L; Folescu T; Marques EA
    Pediatr Pulmonol; 2009 Apr; 44(4):392-401. PubMed ID: 19283764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G
    Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BPI-ANCA of pediatric cystic fibrosis patients can impair BPI-mediated killing of E. coli DH5alpha in vitro.
    Schultz H; Schinke S; Mosler K; Herlyn K; Schuster A; Gross WL
    Pediatr Pulmonol; 2004 Feb; 37(2):158-64. PubMed ID: 14730661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome.
    Sinico RA; Di Toma L; Maggiore U; Bottero P; Radice A; Tosoni C; Grasselli C; Pavone L; Gregorini G; Monti S; Frassi M; Vecchio F; Corace C; Venegoni E; Buzio C
    Arthritis Rheum; 2005 Sep; 52(9):2926-35. PubMed ID: 16142760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low gammaglobulin subclass 2 levels in paediatric cystic fibrosis patients followed over a 2-year period.
    Garside JP; Kerrin DP; Brownlee KG; Gooi HC; Taylor JM; Conway SP
    Pediatr Pulmonol; 2007 Feb; 42(2):125-30. PubMed ID: 17186508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis.
    Hartl D; Griese M; Kappler M; Zissel G; Reinhardt D; Rebhan C; Schendel DJ; Krauss-Etschmann S
    J Allergy Clin Immunol; 2006 Jan; 117(1):204-11. PubMed ID: 16387607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal and paranasal sinus endoscopy, computed tomography and microbiology of upper airways and the correlations with genotype and severity of cystic fibrosis.
    Sakano E; Ribeiro AF; Barth L; Condino Neto A; Ribeiro JD
    Int J Pediatr Otorhinolaryngol; 2007 Jan; 71(1):41-50. PubMed ID: 17007941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis.
    Zuercher AW; Horn MP; Que JU; Ruedeberg A; Schoeni MH; Schaad UB; Marcus P; Lang AB
    FEMS Immunol Med Microbiol; 2006 Jul; 47(2):302-8. PubMed ID: 16831219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis.
    Kraemer R; Deloséa N; Ballinari P; Gallati S; Crameri R
    Am J Respir Crit Care Med; 2006 Dec; 174(11):1211-20. PubMed ID: 16959918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular typification of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
    Iglesias NG; Marengo JM; Rentería F; Gatti B; Segal E; Semorile L
    Rev Argent Microbiol; 2008; 40(1):3-8. PubMed ID: 18669045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis.
    da Silva Filho LV; Tateno AF; Martins KM; Azzuz Chernishev AC; Garcia Dde O; Haug M; Meisner C; Rodrigues JC; Döring G
    Pediatr Pulmonol; 2007 Oct; 42(10):938-44. PubMed ID: 17722007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.